| Names | |
|---|---|
| Preferred IUPAC name | 2-Hydroxybenzoic acid |
| Other names | 2-Hydroxybenzoic acid o-Hydroxybenzoic acid Salicylate |
| Pronunciation | /ˌsæl.ɪˈsɪl.ɪk ˈæs.ɪd/ |
| Identifiers | |
| CAS Number | 69-72-7 |
| Beilstein Reference | 2040220 |
| ChEBI | CHEBI:16914 |
| ChEMBL | CHEMBL25 |
| ChemSpider | 5292 |
| DrugBank | DB00936 |
| ECHA InfoCard | 100.003.601 |
| EC Number | 204-673-3 |
| Gmelin Reference | 14422 |
| KEGG | C00719 |
| MeSH | D017050 |
| PubChem CID | 338 |
| RTECS number | VO0700000 |
| UNII | O414PZ4LPZ |
| UN number | UN2585 |
| Properties | |
| Chemical formula | C7H6O3 |
| Molar mass | 138.12 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.44 g/cm³ |
| Solubility in water | 0.2 g/100 mL (20 °C) |
| log P | 2.26 |
| Vapor pressure | 1 mmHg (at 148°C) |
| Acidity (pKa) | 2.97 |
| Basicity (pKb) | pKb = 11.6 |
| Magnetic susceptibility (χ) | -70.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.565 |
| Viscosity | Medium viscosity |
| Dipole moment | 2.15 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 165.0 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -492.5 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -3166 kJ/mol |
| Pharmacology | |
| ATC code | N02BA03 |
| Hazards | |
| GHS labelling | GHS07, GHS05 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P264, P280, P305+P351+P338, P337+P313, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 2-1-0 |
| Flash point | 113 °C |
| Autoignition temperature | 410°C |
| Lethal dose or concentration | LD50 oral rat 891 mg/kg |
| LD50 (median dose) | LD50 (median dose): 891 mg/kg (oral, rat) |
| NIOSH | SA287 |
| PEL (Permissible) | 5 mg/m³ |
| REL (Recommended) | 2% |
| IDLH (Immediate danger) | 80 mg/m³ |
| Related compounds | |
| Related compounds | Acetylsalicylic acid Salicylamide Methyl salicylate Sodium salicylate 2,3-Dihydroxybenzoic acid Gentisic acid p-Hydroxybenzoic acid Anthranilic acid Benzoic acid |
| Product Identification | |
|---|---|
| Product Name | Salicylic Acid |
| IUPAC Name | 2-Hydroxybenzoic Acid |
| Chemical Formula | C7H6O3 |
| CAS Number | 69-72-7 |
| Synonyms | Ortho-hydroxybenzoic acid, o-Hydroxybenzoic acid, 2-Carboxyphenol |
| Trade Names | Salicyl, Sal Acide, Salisylsäure, Acide Salicylique |
| HS Code | 291821 |
| Customs Classification | Salicylic acid and its salts – Organic Acids and Derivatives |
On an industrial scale, salicylic acid synthesis most frequently involves a Kolbe-Schmitt process, which utilizes sodium phenolate and carbon dioxide under elevated pressures. Selection of raw materials is based on phenol purity and consistent particle size, both of which impact conversion rates and impurity profiles. Carbonation stage control helps determine the final product color and residual inorganic content. Downstream, the acidification and filtration steps are optimized for minimum loss and targeted particle morphologies.
Each production batch brings variations based on operational parameters, grade, and customer requirement. Technical, pharmaceutical, and cosmetic grades differ in purification steps and impurity thresholds. Higher purity is usually achieved via repeated recrystallizations, but increased washing volume or altered temperature cycles may shift residual inorganic or organic profiles.
Every lot follows in-process controls: pH, insolubles, and color are monitored across stages. Low organic contamination is critical for pharmaceutical applications, while technical grades tolerate wider inorganic margins based on downstream utility. Shelf-life and storage sensitivity depend on trace moisture, iron, and organics, influencing color stability and caking during warehouse holding.
Specifications, whether for color, heavy metals, or particle size, reflect the end-use (e.g., API, food preservative, rubber accelerator). Final release depends on cumulative test results, validated against internal controls and any customer-agreed criteria. Customer-provided standards often require parallel method validation with our QC benchmarks for release.
International shipments rely on accurate HS code (291821) to streamline global logistics. Declarations must align with product purity and end-use, since some jurisdictions apply preferential duties or special controls for ingredients intended for pharmaceuticals versus technical applications. Traceability extends to every label and certificate, preventing customs delays, especially for regulated industries.
Salicylic acid leaves our line in crystalline solid or fine powder form, most commonly distinguished by a white to off-white appearance. Visual assessment remains a core tool during manufacturing, as trace discolorations often indicate impurity carryover or degradation — especially relevant at large scale where brief thermal excursions during drying or milling can cause yellowing. The faint phenolic odor, noticeable at high concentration, signals batch freshness and purity. Melting behavior varies with grade: pharmaceutical batches require reproducibility in melting range, while industrial grades show slightly broader transition due to permitted minor impurities. Boiling and flash point data, though less relevant since salicylic acid sublimes before significant volatilization, serve as safety checks for fire risk in large dryers and blending pits. Density impacts flow and packing; denser lots may indicate moisture or low-molecular-weight impurity inclusion.
Process upsets, especially overexposure to acidic or basic conditions, lead to hydrolysis or oxidation. Most technical complaints trace back to storage or transfer conditions, not just process errors. Elevated humidity drives caking and accelerates self-esterification, especially near exposed packaging. Reactivity considerations affect not only shipment labeling but also the design of stainless or lined-steel plant components, as contact with certain metals or alkalis fosters discoloration and trace metal pickup.
Water solubility is limited and highly temperature dependent. Technically, batch solution prep in production uses heated, agitated vessels for pharmaceutical or cosmetic applications, aiming for maximized dissolution and uniformity. Solvent choice alters impurity extraction; ethanol and alkali are typical on pilot scale for analytical sample preparation. Solubility data must match the end-use sector’s needs, as colorimetric or turbidity changes during solution prep often flag trace contaminant or residual process solvent issues.
| Parameter | Pharma Grade | Industrial Grade | Cosmetic Grade |
|---|---|---|---|
| Appearance | White crystalline powder | White/off-white powder | White powder |
| Assay (as C7H6O3) | Grade-dependent | Grade-dependent | Grade-dependent |
| Melting Range | Tight range | Standardized | Standardized |
| Impurities (total/by type) | Internally defined | Process route-dependent | Application-driven |
| Loss on drying | Specification-driven | Process-controlled | Requirement-driven |
Known impurities include residual phenol, unreacted raw materials, and byproducts such as dihydroxybenzoic acids and iron traces from corrosion. Grade dictates the allowed levels of related compounds — pharmaceutical and food sector shipments must pass rigorous batch chromatographic review and elemental analysis, especially when destination country regulations diverge. Industrial grade tolerances permit higher residuals, but overall batch acceptance follows customer-specified and internally validated maxima.
Testing follows compendial monographs for pharmaceutical shipment (e.g., USP, EP, JP for assay, residual solvents, and metals analysis) and in-house validated methods for industrial or technical grade. Melting point by microcapillary, HPLC for related compounds, specific spectrophotometric assays for residual solvents, and trace metal analysis by ICP remain standard. Final release samples undergo routine comparison against retained reference lots, emphasizing traceability and historical deviation control.
Production starts with refined phenol; the selection logic prioritizes low-water, low-metal sources to prevent corrosion and side reaction formation. Input CO2 purity and moisture control are critical in the Kolbe-Schmitt process, as out-of-spec sources produce tarry byproducts or excess unconverted feedstock. Many markets require full traceability of raw material origins for regulatory assurance.
The Kolbe-Schmitt carboxylation remains the backbone of industrial production — phenol reacts with sodium hydroxide to generate sodium phenoxide, followed by high-pressure, high-temperature carboxylation with carbon dioxide. Reaction completion demands rigorous temperature and pressure management; deviations increase undesired ortho- and meta-isomers, lowering batch yield and complicating purification.
Continuous pH monitoring, online temperature and pressure logging, and staged CO2 delivery stand as critical control points. Acidification and filtration separate crude salicylic acid, while multi-stage recrystallization and washing remove colored byproducts and residual sodium. Quality improvement follows direct analysis of mother liquor and solid fractions, driving optimization of solvent ratios and filtration media.
All product lots undergo staged in-process controls and are benchmarked via comparison with historical high-performing batches. Assay repeatability, moisture content, and appearance screening join instrument-based impurity profiling as release gatekeepers. Final customer acceptance can depend on endpoint-use testing, especially where dye pick-up, formulation stability, or regulatory documentation are pivotal.
Salicylic acid serves as both a direct active and an intermediate; common modifications include esterification for aspirin (acetylsalicylic acid), and salt formation for topical pharmaceutical use. Hydroxyl and carboxyl groups undergo predictable substitution under controlled conditions, allowing customization. Reactivity tuning requires strict management of reaction pH, choice of organic or inorganic catalyst, and solvent selection tailored to minimize side-product formation.
Catalyst, solvent, and temperature selection vary widely with the intended transformation. For acetylation, acetic anhydride under mild acid catalysis and moderate heating is common. Industrial and bulk downstream transformations respect solvent compatibility and environmental controls due to batch size and waste minimization mandates. Side reactions, such as etherification and oxidative decarboxylation, are more prevalent under uncontrolled heating or in the presence of transition metals.
Bulk of commercial demand ties to aspirin, dyes, and ultraviolet absorbers. Derivative scope covers both pharmaceutical actives and functionalized intermediates for pigment, polymer, and agrichemical applications.
Salicylic acid maintains quality longest in cool, shaded, dry areas. Cross-contamination risk rises in non-dedicated warehouses where shared stacking exposes product to volatile organics or acidic vapors. Metal contact, especially with non-passivated surfaces, prompts color and odor shifts due to trace catalysis. Dual-lined fiber drums or HDPE containers prove robust; permeation and atmospheric water pickup are rarely observed with correct closure. Customer-specific microcontamination issues, such as mold sensitivity or particulate limits in high-purity applications, influence both packaging format and secondary containment.
Batch history confirms that mild steel or aluminum containers promote trace metal pickup and localized degradation, particularly with recycled drums. Dedicated, lined, or high-performance polymer containers provide best results, especially for export shipments or long-term storage where temperature excursions are likely.
Shelf life is not universal: it depends on storage practices and product grade. Pharmaceutical users often specify maximum holding times under their own environmental controls. Degraded lots manifest as color shift, aggregation, or off-odor. Moisture ingress triggers clumping and may initiate hydrolysis, which must be checked before downstream pharmaceutical or cosmetic use.
Salicylic acid generally receives classification as hazardous upon acute exposure. Production and filling departments implement GHS-compliant labeling, guided by both global and destination-specific requirements. Local risk assessments set further controls at the workplace level, especially where batch size and airborne particulate potential increase exposure risk.
Direct skin and eye contact leads to irritation. Inhalation of dust above occupational background levels creates risk of respiratory irritation. Each drum and shipping carton carries technical safety statements in accordance with both GHS and regional transport safety protocols. Risk-mitigation measures, like spot extraction and fixed-line ventilation at critical operations, lower daily exposure but never completely remove risk in large-scale handling.
Acute toxicity varies with exposure mode; most complaints arise from repetitive direct handling or accidental ingestion by non-trained personnel. Technical and QC departments track global case reports and update internal guidelines for lab workers and bulk handlers. The most conservative limits apply for pharmaceutical and cosmetic production rooms, where uncontrolled transfer can trigger costly cross-contamination events.
Handling procedures follow internally validated safety protocols based on workplace monitoring. Airborne dust levels receive regular measurement in filling and repackaging rooms. Full protective wear, including gloves, safety goggles, and local dust extraction, is prescribed for all batch operations. Automated and enclosed transfer systems reduce risk in updated facilities; legacy lines require stricter personal monitoring. Technical data sheets support downstream processors in defining their own operator protection standards, especially when blending, micronizing, or formulating in open environments.
Our approach to salicylic acid production relies on integration of raw material sourcing and multi-step phenol oxidation reactions, with capacity scale closely linked to upstream phenol and sodium hydroxide supplies. Output volumes depend strongly on line utilization rates, plant maintenance schedules, and environmental compliance cycles. Production rationalization results from cyclical shutdowns for emission control system upgrades, so availability in tight quarters reflects both seasonality and regional regulatory constraints. Specifications for food, pharmaceutical, and technical grades define dedicated production lines and unique in-process monitoring standards, with qualification runs required before resuming GMP and food-compliant batch series. Availability for spot orders can shift even within a single quarter based on refinery outages or shipping disruptions affecting phenol imports. Contract quantities for high-purity and micronized grades often follow quarterly or semi-annual allocation agreements to ensure consistent supply to downstream formulators.
Lead times depend on grade and packaging requirements. Pharmaceutical and food grades, due to sterilization and cross-contamination prevention, require extended release timelines to cover cleaning validation and quality assurance batch testing. For standard technical grade, turnaround from order confirmation to readiness for dispatch remains shorter, contingent on available batch stock and final impurity screening results. Contract buyers supplying regulated industries typically observe higher MOQs reflecting both clean line constraints and logistics cost efficiency. Custom low-MOQ arrangements are common for R&D quantities, but ongoing industrial use aligns packaging lot size to containerized palletization standards and freight optimization.
Industrial production supports a range of packaging solutions. Most technical grades ship in 25 kg fiber drums or polyethylene-lined bags, subject to customer-requested secondary containment or inert gas flushing. Specialty applications require tighter moisture and contamination controls, triggering use of foil-lined drums, double-bagging, or nitrogen-purged containers. Packaging change requests often trigger additional verification for compliance with food or pharma transport regulations. Package selection impacts both shelf stability and in-transit exposure risk, with granular and powder forms requiring improved anti-caking measures for humid climate shipping routes.
Shipping methods reflect volume, regulatory status, and final destination. Bulk shipments to high-volume end users may use ISO tanks for dissolved forms, but powder grades primarily move by container freight, packed in double-layered bags or sealed drums. Built-in incoterms (FOB, CFR, DAP) depend on customer shipping preferences and the need for in-transit insurance. Standard payment cycles adjust in proportion to aggregate contract value and customer credit assessment, with letters of credit or advance payment required for new clients, especially for non-standard packaging or expedited production. Customs documentation and compliance certification, including REACH, FDA DMF, and Kosher/Halal if applicable, adjust final shipping release timing.
The price level draws most of its volatility from the raw material chain—primarily phenol, caustic soda, and energy input for oxidation and purification. Fluctuations in benzene feedstock costs for regional phenol synthesis filter directly down to the cost base of salicylic acid, impacting spot and contract pricing within the quarter. Environmental control and process waste treatment costs, particularly for mother liquor recovery and wastewater management, create significant cost differentials between Asian integrated plants and Western producers with stricter compliance mandates.
Feedstock swings, particularly on phenol or benzene, reshape the cost landscape. Environmental regulatory escalations, power price spikes, and labor contract adjustments in major manufacturing hubs (e.g., Jiangsu Province, India’s Gujarat belt) rapidly shift ex-works cost structure. Market tightness based from planned or unplanned plant turnarounds among leading producers can trigger surge pricing. Regulatory changes—such as REACH bans on certain byproducts or added GMP protocol for food/pharma supply chains—add cost layers by necessitating process audits and additional third-party certification runs.
Grade and purity stand as the core price discriminants between technical, food, and pharmaceutical salicylic acid. Food and pharma grades require upstream input traceability, impurity profiling, and full-batch analytical documentation. These specifications command higher pricing not only for extra purification cycles—such as recrystallization, micronization, or multi-stage filtration—but also for the extended quality hold pending regulatory and customer audit. Packaging certification (such as BRC, ISO 15378) can result in material and labor premiums, particularly where sterile/loading and serialized tracking are mandatory. Downstream requirements for allergen status, heavy metal content, and microbiological control drive price up further for food/pharma batches.
Market balance in salicylic acid rests on fluctuating demand for downstream products in personal care, pharmaceuticals, and industrial preservatives. China leads supply with high-capacity, phenol-integrated plants, followed by India, which prioritizes domestic demand and specialty grade expansion. EU and US output mostly targets specialty grades, facing higher cost floors due to labor, waste treatment, and emissions control. Japan acts as a niche supplier with tight customer integration, focusing on high-purity and customized forms. Supply disruptions—typhoon season in East Asia, logistics delays at Indian ports, or regulatory shifts in Europe—ripple quickly through price offers.
China attributes its competitive pricing to hydro-integration and favorable cost structure in raw materials. Importers in the US and EU pay higher premiums due to regulation-driven plant operation cost and higher input traceability for food/pharma applications. Indian production captures custom formulation segments but remains exposed to irregular power and feedstock supply. Japanese producers, while stable, price at a premium for low-volume, high-purity markets and maintain enduring relationships with established pharma and personal care formulators. Each market segment follows a unique grade mix, specification stringency, and compliance documentation standard, affecting both delivered cost structure and final market offering pricing.
Forward projections indicate cost pressures from continued environmental regulation tighten supply amongst traditional low-cost producers, while slow but steady headwinds from electric power pricing and plant consolidation drive gradual upward price tendencies in the US and EU. Price differentials between basic technical, food, and pharmaceutical grade are expected to widen further, as segmented regulatory regimes increasingly separate specialty supply chains from bulk industrial markets. Sporadic regional supply disruptions—whether from weather, logistics, or periodic famines in phenol or caustic soda availability—are anticipated to create quarter-to-quarter price variability. Sustained increases in demand for dermatological, cosmetic, and niche preservation uses may push capacity utilization in Asia higher, but ongoing scrutiny over plant emissions and wastewater discharge presents a moderating factor on supply expansion rates.
Price, volume, and compliance trends referenced above arise from long-term contract monitoring, regular upstream raw material market surveys, trade association bulletins in major export hubs, and quarterly reports from regulatory filing agencies. Direct customer audit feedback, import/export statistical data, and supplier tender tracking add additional corroboration. Grade- and region-specific trends draw on plant-level custom reporting and third-party laboratory certification results for recurring batches.
The past year brought site expansions in South and East China as integrated complexes came onstream after local environmental review cycles. Major players in India undertook GMP process upgrades for new export accreditations and specialty grade launches. Periodic shutdowns in EU facilities for emission capture retrofits briefly constricted availability, pushing up short-term contract prices for high-purity and micronized variants. International shipping constraints, especially out of Asian export ports, contributed to extended lead times and demand for increased in-country inventory holdings by downstream users.
Stringent new wastewater discharge regulations in the Yangtze River basin forced process revisions and batch record upgrades in major Chinese production plants. The EU updated its reach substances-of-very-high-concern (SVHC) criteria, requiring adaptation of documentation protocols and occasional reformulation for certain industrial customers. Rising demand for full chain-of-custody documentation among North American and EU pharmaceutical importers intensified demand for validated, traceable batch processes and heightened scrutiny during compliance audits. Ongoing global harmonization efforts for food and pharma grade batch certification (WHO GMP, US FDA, EU FSSC) entrenched the need for additional investment in quality management infrastructure.
In response to upstream cost hikes and regulatory tightening, leading producers upgraded purification units and automated process monitoring to enhance lot-to-lot consistency while minimizing human handling. Investments in secondary mother liquor recovery, solvent reclamation, and effluent treatment reduced cost exposure to tightening discharge caps. Diversifying logistics routes—for example, cross-border rail in Central Asia and expanded warehousing near EU ports—helped offset volatility in ocean container availability. Adaptation to rapid changes in regulatory regimes now relies on agile compliance teams and robust digital batch record systems, minimizing release delays for regulated grade shipments.
Salicylic acid serves multiple industrial fields, such as pharmaceuticals, cosmetics, personal care, food preservation, animal feed, and industrial intermediates. Production departments respond to different requirements for purity, particle size, water content, and impurity profiles, depending on the targeted downstream process. Raw material sourcing, plant hygiene, and segregation standards play a central role in identifying which sectors a batch can enter. For example, topical pharmaceutical formulations demand tighter control of heavy metals and fine particle sizing, while agricultural uses tolerate wider variation in visual color and trace contaminant level.
| Industry Field | Common Grade(s) | Purpose / Functional Role |
|---|---|---|
| Pharmaceutical (API/Excipient) | USP/Ph.Eur./JP | Acne medications, topical keratolytic, API synthesis intermediate |
| Personal Care & Cosmetics | Cosmetic, Technical Pure | Exfoliant, anti-dandruff, skin-conditioning agent |
| Food & Animal Feed | Food/Feed Grade | Preservative, microbial growth inhibitor |
| Industrial & Chemical Synthesis | Technical, Industrial | Dye manufacturing, rubber vulcanization, preservative in adhesives |
Assignments depend on batch impurity spectra, odor, color, and preparation process. Blending or post-purification steps often determine which segment receives a given consignment.
Begin by clarifying target market: pharmaceutical, food, cosmetic, or industrial. This decision affects required regulatory certification and the scrutiny applied to starting materials and process routes. In-house batch selection often depends on expected destination sector, because deviation in purity profile shifts the batch out of certain regulated uses.
Regulations may set limits on process impurities, heavy metals, pathogens, and even packaging materials. The production department cross-references raw material batch records with customer standards (USP, Ph.Eur., FCC, etc.) to ensure release alignment. For pharmaceutical sales, traceability and documentation systems need to provide detailed impurity-tracking capability through the full production lifecycle.
Packing, storage, and transport introduce potential for cross-contamination. QA teams review both intrinsic purity and the risk of extrinsic contamination. Requirements for microbiological purity, color index, volatile content, or crystalline structure directly influence which grade is offered. Where tight lot tracking is needed, QA organizes physical segregation and extra documentation audits.
Large-volume technical users often select technical grades, accepting wider purity fluctuation in return for cost savings. Pharmaceutical and cosmetic manufacturers order in smaller lots but require enhanced lot documentation and increased scrutiny at goods-inward inspection. Rarely, some downstream processers request customized packaging or split lots to match their storage or formulation scale, which guides packaging and secondary handling unit department workflow.
After selecting a provisional match, most customers validate with a batch sample. This practice reveals issues related to reactivity, compatibility, or appearance not evident in a general certificate of analysis. Feedback triggers possible process modifications—switching drying protocol for color stability, or shot-blasting to reduce fine powder content for certain dispensers. Production and QC teams adjust batch selection criteria according to repeat customer results in real-life use conditions.
Production of salicylic acid requires an integrated quality management system that extends from raw material qualification to final product dispatch. Consistent compliance with internationally recognized quality standards, such as ISO 9001, depends on regular internal and external audits, daily process documentation, and transparent corrective actions. Systematic training calibrates lab and production staff. Traceability in raw material sourcing ensures batch reproducibility, reduces risk of cross-contamination, and backs up root cause investigations for any deviation.
In salicylic acid manufacturing, certifications align with customer targets, regulatory frameworks, and global destination markets. Pharmaceutical and food-grade salicylic acid production responds to GMP compliance and, case-sensitive, to regional pharmacopeia monographs. Cosmetic grades face external scrutiny driven by REACH, FDA, or relevant national chemical registration. Conformance documentation adjusts to the grade and market regime, and certain customers may require tailored audit trails on top of the default scheme.
For each delivery, technical documentation reflects real-time batch analysis, COA, COQ, and, if needed, origin of raw materials. Certificates fulfill local and international compliance, shifting in format or content according to regulatory or customer requirements. Typical reports record analysis of purity, main impurity profile by HPLC, moisture content, ash, content of heavy metals, and, for pharmaceutical or food-related use, established exclusion of specific contaminants. Regulatory statements, residual solvent declarations, and allergen non-use statements are provided when the customer’s supply chain demands.
Salicylic acid supply planning follows historical demand, raw material trends, and foreseeable seasonal shifts. Key plant assets include dedicated reaction vessels, continuous filtration, and controlled crystallization facilities, with a focus on batch-to-batch reproducibility. Decision-making for delivering industrial volumes considers core capacity, production schedule, and contingency safeguards set up for raw material interruptions. For high-purity or low-impurity applications, plant lines are isolated and cleaned per validated SOPs, minimizing cross-batch risks.
Annual line output capacity supports ongoing contract supply and scalable expansion during market fluctuations. On-site storage capability and raw material contracts determine ability to buffer volatility in upstream supply. A two-tier quality control system monitors both in-process and release steps—core steps include purity assessment pre- and post-reaction, intermediate washing, and end product drying before packaging. Each salicylic acid batch’s documentation ties back to these check steps for batch alignment and audit facilitation.
Technical sample requests follow a defined path: customer outlines intended application, minimum purity or impurity thresholds, and critical downstream demands. The sample is matched by grade—technical, cosmetic, pharmaceutical—dependent on intended use. Control samples undergo in-process retention parallel to outbound shipment for follow-up investigation or traceability. Response timelines reflect plant schedule, real-time availability, and regulatory restrictions for export/import of samples in certain jurisdictions.
Cooperation proposals range from fixed-quantity, long-term supply contracts to short-term spot supply for new or shifting customer requirements. Joint process development, custom impurity reduction, or special packaging formats can be negotiated for customers with integrated downstream formulations or unique regulatory targets. Technical liaison support aligns plant QC resources with customer incoming quality control to accelerate qualification and batch alignment. Adaptive shipping formats, staggered deliveries, or volume ramp-up are managed based on line capacity data and historical performance analysis.
Recent work in salicylic acid manufacturing focuses mainly on refining process safety, minimizing batch-to-batch variation, and reducing byproduct formation. Benchmark producers keep raw material sourcing under review, especially the purity of phenol and sodium hydroxide as starting materials, which directly influences downstream impurity profiles. In applied research, chemists work to reduce phenolic odor carryover and optimize crystallization for better filtration rates. In the finished goods segment, pharmaceutical and personal care end-users push for lower trace levels of typical process contaminants, including colored bodies and heavy metal residues, which remain a critical topic in both compliance and customer audits.
The demand for salicylic acid now extends well beyond its traditional roles in pain relief and skincare. In crop protection, it serves as a precursor for new-generation plant protectants. Food preservatives based on salicylate chemistries have emerged for certain niche applications, although regulatory acceptance varies by region. R&D collaborations focus on functional polymers and advanced resins, which need custom specification for hydrolytic stability and residual solvent content. We see increasing requests for technical support from formulators exploring anti-microbial coatings and slow-release delivery systems, which present unique stability and compatibility questions.
The primary technical challenge remains control of impurities at ppm levels, especially aromatic byproduct control from the Kolbe-Schmitt reaction. The drive for low impurity grades forces process engineers to refine temperature, pressure, and residence time, and to maintain high-purity carbon dioxide feeds. Purification strategies involve successive filtration stages and solvent extraction; new ion-exchange resins show promise for selective metal removal, but economics and scalability are still under review. Another area seeing progress is real-time in-process monitoring of crystallization, which helps reduce out-of-spec material. Application specialists validate shelf life, dissolution, and stability for each customer segment, requiring close feedback loops between QC, R&D, and process operations.
Salicylic acid consumption tracks with growth in over-the-counter pharmaceuticals, personal care, and certain agricultural markets. The recent increase in plant-based skincare protocols adds incremental volume. Market analysts anticipate a compound growth trend closely tracking sector development in Asia-Pacific. Major regulatory developments in allowable impurities and evolving standards for pharmaceutical and food additives will drive producers to invest in both analytics and process improvements. Export-oriented models will remain sensitive to logistics cost and evolving tariffs, all of which inform internal planning cycles.
Incremental gains in catalytic performance and continuous-flow adaptation aim to reduce waste and shrink cycle times. Manufacturers investing in advanced in-line analytics, including NIR and HPLC, report tighter release windows and reduced rework. Adoption of digital process controls and predictive maintenance for handling corrosive reactants further minimizes downtime. Raw material efficiency, especially in CO2 management, increasingly factors into cost competitiveness. Each process change requires updated standard operating procedures and retraining for technical and production teams.
Sustainability drivers influence both feedstock sourcing and waste management. Some producers evaluate bio-based phenol derivatives and secondary CO2 capture schemes, subject to supply chain security and lifecycle analysis. Waste minimization programs prioritize recovery and reuse of solvents and water. Environmental compliance rests on region-specific permits, where effluent phenol discharge and energy consumption caps define allowable process windows. Green chemistry principles require ongoing investment in both new equipment and audit documentation, with a growing trend toward external sustainability certification as a market differentiator.
End-use diversification requires dedicated technical consultation teams able to provide material compatibility assessments, impurity traceability support, and up-to-date regulatory dossiers. Application technologists collaborate directly with formulation chemists at the customer, sharing experience with process scale-up, material blending options, and in-process troubleshooting. Documentation provided includes COAs, product origin attestations, and, when requested, custom test protocols according to local or sector standards.
Customers deploying salicylic acid in high-value pharmaceutical or specialist industrial settings can access formulation advisory and stability evaluation support. Batch-specific technical information clarifies trace impurity profiles, physical form data, and flow properties relevant to blending, dissolution, or coating. Advice is tailored by grade, with the technical team remaining available for ongoing application performance feedback, including processing behavior, finished product appearance, and storage stability.
After-sales service extends beyond basic complaint handling. Customer support specialists manage product traceability for each lot, in line with region-specific regulatory requirements. The quality team supplies rapid-response failure analysis and root-cause investigations if product performance deviates in downstream use. Long-term users benefit from ongoing process audits, periodic technical briefings, and proactive notifications if process changes could impact agreed specifications. Commitment to transparency means all technical queries receive documented follow-up from the relevant internal function, whether QC, R&D, or production engineering.
Our facility manufactures salicylic acid at industrial scale using refined neutralization and crystallization techniques. We control every process step from raw material selection to final drying and screening. This means technical and pharmaceutical buyers receive material that aligns with strict batch specifications on purity, particle size, and trace contaminants. Our in-house labs review every production lot, running HPLC, titration, and heavy metal testing to ensure specification compliance. Documentation for each batch supports traceability and audit needs common in regulated sectors.
Salicylic acid serves as a core precursor and additive across multiple downstream industries. In polymers, it acts as a key modifier for chemical synthesis, particularly for certain resins and stabilizers. Within pharmaceuticals, it supports aspirin and dermatology product lines. Food manufacturers rely on salicylic acid for preservative functions in controlled-use applications. Dyes and rubber processing adopt it for its chelating, stabilizing, and crosslinking behavior. Consistent physical and chemical profiles are critical, as production interruptions or raw material shifts can disrupt formulation and batch yields.
As the direct manufacturer, we develop and update all process control plans in response to lot data, process drift, and evolving industry standards. This direct approach lets us deliver material with low impurity profiles and minimized batch-to-batch variation. We never transfer quality control responsibility to third parties or outsource critical testing.
We pack salicylic acid using fiber drums, plastic lined kraft bags, or bulk containers to suit customer throughput and storage environments. Packing lines operate with dust control and auto-sealing equipment to prevent exposure and maintain shelf life. Every unit leaves with batch records and seals documented by our logistics team. Container or warehouse consolidation is handled in-house for customers running multiple product lines or international production cycles. We maintain buffer inventory and flexible production windows to support seasonal or contract-driven demand spikes.
Our client technical specialists answer formulation and process integration questions, whether fielding issues on solubility in alkali blends, reaction kinetics in resin production, or effect of impurities on pharma production margins. We provide real-world data from our own pilot batch systems to help partners optimize usage, troubleshoot scale-up issues, or implement process changes. We share best practices based on years of large-volume manufacturing for customers seeking to improve margin, reduce flow interruptions, or manage regulatory change across plants.
Direct-from-factory procurement eliminates markups and uncertainty common in fragmented supply chains. Our integrated operations offer reliability in delivery scheduling and volume flexibility—assets for large manufacturers and distribution partners balancing dynamic end-user demand. Procurement teams leverage physical and technical access to our production and R&D staff, streamlining problem resolution or rapid specification updates. Full disclosure on process changes or raw material supply lets downstream customers maintain compliance with changing regulatory requirements. This mitigates cost overruns, delivery interruptions, and quality disputes.
| Aspect | Factory Practice |
|---|---|
| Quality Control | Direct in-house testing, batch traceability, detailed documentation |
| Packing & Logistics | Modern packaging lines, flexible unit sizes, in-house supply chain handling |
| Technical Support | Access to plant specialists, real-world process data, batch issue troubleshooting |
| Procurement Value | Single-point supply, rapid adjustment to client needs, compliance tracking |
We continuously upgrade our plant infrastructure and analytical capacity so material delivered supports the needs of modern polymer, pharmaceutical, and chemical synthesis facilities. By owning production and supply, we help partners minimize supply interruptions, reduce cost fluctuations, and maintain confidence in every ton received.
Our salicylic acid meets rigorous demands for purity, especially where pharmaceutical and cosmetic applications dictate performance and safety. Through each batch, our quality control lab tracks every critical value, drawing on validated analytical techniques such as HPLC and GC-MS to measure both major and trace-level species. We typically produce salicylic acid with a minimum purity of 99.5%. These results stem from established crystallization and washing processes that continuously limit residual organics and inorganic contaminants.
We follow strict regulatory and customer-driven guidelines for the impurity profile. Trace levels of phenol, commonly a process-related impurity, get monitored closely—industry standards keep levels well below 0.2%. Total related substances, such as 2,3-dihydroxybenzoic acid or 4-hydroxybenzoic acid, remain under 0.5% in our typical lots. Sulfated ash, representing inorganic residue, consistently runs less than 0.05%. Chelating and coloring agents have no role in our process, so those classes of impurity do not appear in our finished material.
Heavy metals, specifically lead, mercury, and arsenic, have dropped well below globally recognized thresholds—lead comes in under 2 ppm for specialty pharmaceutical grades. Chloride and sulfate anions both fall below 0.02%. In response to the growing regulatory push on nitrosamines and other genotoxic impurities, we run expanded checks on request. Microbial endotoxins do not present issues for solid salicylic acid, based on controlled environments and careful choice of transport materials.
Continuous feedback from downstream partners demands solid product consistency. Our technical team refines the manufacturing workflow to suppress formation of colored tars and process byproducts. By maintaining strict control over raw material quality and intermediate purification steps, we reduce impurity formation at its source—critical for both large-volume pharmaceutical clients and specialist chemical formulators.
Beyond routine testing, our plant operates traceability systems so any unexpected variation in impurity signals triggers immediate review. Storage and packaging conditions play a role too—by offering salicylic acid only in moisture-proof, inert-lined drums or bulk sacks, we safeguard against contamination that could arise during storage or transit.
Different customers set different benchmarks for purity and permitted impurities. For pharma and personal care, we maintain batch documentation for all certificates of analysis, including impurity fingerprints. Food and technical grades get similar scrutiny, with detailed reports available upon request. Many users reference pharmacopeial standards like the USP, Ph.Eur., and JP; our facility holds daily checks against these values for the relevant grades in ongoing production.
We maintain transparency for any client needing to audit analytical procedures, supply detailed impurity maps, or validate their own test methodology. All lab data, retention samples, and historical batch trends can be made available for compliance or troubleshooting purposes.
Demands on impurity control only grow as downstream regulations tighten. Our investment in better separation technologies, refined crystallizers, and in-house synthesis analytics pays off in cleaner material and higher confidence for end users. Since every plant faces changing environmental rules and new limits on trace contaminants, our response is straightforward: strengthen real-time oversight, increase documentation, and never lose focus on high-purity results.
In today’s chemical supply landscape, direct engagement with authentic producers has become crucial. As a long-standing manufacturer of salicylic acid, we have witnessed how transparent supply chains, direct technical support, and assured product integrity build confidence among end users across pharmaceutical, personal care, and industrial markets. With growing scrutiny on sourcing channels, knowing the difference between genuine manufacturing sources and intermediaries can make a direct impact on business continuity and material traceability.
Within industrial sectors, an ‘approved supplier’ refers to a party that maintains complete control over synthesis, testing, packaging, and documentation of supplied materials. Only the companies that operate their own production facilities, oversee raw material sourcing, and run on-site analytical labs can genuinely fit this definition in the case of core chemicals such as salicylic acid. By controlling every aspect of the process—starting from raw benzoic acid through high-precision carboxylation and recrystallization—direct manufacturers ensure consistent purity, batch traceability, and validated compliance with pharmacopoeial standards.
Far too often, buyers encounter sales organizations claiming access to ‘factory-direct’ material, but these traders neither operate plants nor hold responsibility for product consistency, change management, or quality assurance audits. Our company works directly with procurement teams, quality managers, and auditors to support all customer requirements—from documentation to process validation—without intermediary distortions. This approach has protected supply chains through market volatility and regulatory tightening, especially in the pharmaceutical and cosmetics sector.
Establishing rational minimum order quantities (MOQs) aligns with how manufacturers plan production campaigns, manage stock, and maintain product freshness. In our facility, we calibrate MOQs around standardized packaging, plant scheduling, and current global demand. For salicylic acid, the lowest MOQ frequently requested by customers is one standard pallet—typically 500 kilograms—packed in fiber drums or 25-kilogram bags suitable for both bulk handlers and repackaging operations. Lower volumes can disrupt operational efficiency, increase the odds of contamination during repacking, and generate unnecessary waste or documentation overhead.
For specialty sectors or R&D needs, we maintain samples and pilot lots; however, these come from separate validated batches and go through stringent sample management protocols so as not to disrupt mainline GMP production. Larger customers ordering by full-container or multi-ton lots benefit from direct loading at the factory, optimized freight rates, and custom labeling or technical support based on SAP batch tracking and customer-specific specifications.
Buyers from regulated sectors value the ability to audit our process and review documentation on site. GMP and ISO-compliant production environments require more than a compliance certificate—traceability and transparency must be woven through every kilogram shipped. We welcome technical due diligence from corporate customers and regulatory authorities. INCI registration, DMF access, and TSE/BSE statements form part of our core documentation set for all approved lots leaving our facility.
From firsthand experience, streamlining supply through direct manufacturing ensures purchasers receive consistent analytical profiles with each delivery and empowers them with responsive quality and technical support. By affording visibility, stability of contract fulfillment, and direct documentation access, chemical manufacturing partners remove the risks associated with unknown intermediaries and reinforce long-term procurement resilience, especially for high-purity salicylic acid applications. We do not trade in speculation—our orders ship from our facility, and our standards reflect what we deliver, every time.
Shipping salicylic acid across borders requires detailed planning and strict compliance. Our experience as a direct manufacturer has demonstrated that every step in the process can impact both safety and speed of delivery. We continually update our protocols to keep pace with international rules and customer priorities.
Our production output typically ships in industrial-grade, tightly sealed HDPE drums or fiber drums lined with polyethylene bags, depending on batch volume and destination. For large consignments, we deploy IBCs or palletized drum loads. We select packaging robust enough to withstand mechanical stress during transit and mitigate any risk of product leakage or contamination. Our packaging choices come after extensive compatibility testing to verify material resistance to salicylic acid under a range of humidity and temperature conditions.
The outer containers feature tamper-evident seals and are rated to UN standards – not just for our own peace of mind, but because customs authorities expect it. We apply batch-specific lot numbers directly to the container so that origin and compliance history remain traceable to the precise production run. This approach has reduced customs inspection delays for our customers over the years.
International markets impose their own requirements, but the stakes go beyond paperwork. GHS (Globally Harmonized System) labeling informs all parties in the supply chain about potential hazards. Each drum or bag carries hazard pictograms, the proper shipping name, hazard class (6.1 for toxic substances), UN number (UN 1489 for salicylic acid), and handling instructions in English or bilingual formats. We source our label sheets using solvents and adhesives tested for chemical inertness, as recurring issues with label deterioration can trigger extra scrutiny at marine or air ports.
Our team always includes the Safety Data Sheet (SDS) with every shipment, and we keep an electronic copy accessible in a backend database for regulatory checks. For destinations in the EU, North America, and selected Asian markets, we attach CLP or OSHA-compliant information so that importers have a clear record for onward storage and logistics.
Ground, sea, or air – each shipping mode brings unique compliance points. Salicylic acid is not classified as highly flammable but falls under toxic solids, triggering special cargo rules with most carriers. Our shipping department prepares a full Dangerous Goods Declaration aligned with the IMDG Code for ocean freight and IATA/ICAO for air deliveries. Port authorities and airlines will cross-check documentation with container labels, so omissions cause immediate rejections.
We build relationships with freight agents who have demonstrated knowledge of chemical cargo. Lapses in documentation, incorrect UN numbers, or missing hazard placards often result in costly demurrage or returns. Our shipments include emergency response instructions to help handlers and authorities manage any unlikely incidents en route. With every load, our documentation supports seamless passage through customs and reduces bottlenecks caused by regulatory ambiguities.
Our compliance team follows updates from shipping authorities, environmental agencies, and chemical regulatory networks. An amendment to packaging codes or the GHS standard can mean overhauling batch labeling templates. We invest in staff training and maintain close dialogue with destination customs offices to minimize the risk of live shipments facing changing interpretations of the law.
Working factory-direct gives us end-to-end visibility and control. When customers request modifications to fit local requirements—such as language variants, special placarding, or reduced package sizes for restricted-entry jurisdictions—we consult directly with our technical and quality assurance departments rather than outsourcing the task to third parties.
From raw material input to final dispatch, our plant-based teams track each batch through digital and manual verification. We use this system to increase accuracy, respond fast to regulatory feedback, and resolve any logistical misalignments before they impact our partners. By controlling every variable in the packaging, labeling, and transportation phase, we enhance reliability for every international shipment of salicylic acid leaving our facility.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
